Posters

DMEK and re-DMEK in iridocorneal endothelial syndrome: a case report

Poster Details

First Author: M.Berges Marti SPAIN

Co Author(s): A. Andrade   E. Cilveti   E. Kirkegaard   B. Azarfane   J. Oliveres   L. Bisbe     

Abstract Details

Purpose:

To report a case of a Descemet membrane endothelial keratoplasty (DMEK) in a patient diagnosed of Chandler’s Syndrome with primary success and late onset failure, which was successfully treated with a re-DMEK with a follow up of one year.

Setting:

Cornea and Ocular Surface Unit. Vall d’Hebron Hospital. Barcelona. Spain.

Methods:

A single case report is presented. We present a case of a patient diagnosed with Chandler’s syndrome and its follow up with topographies (Sirius Topograph), anterior segment OCT (Swept Source DRI OCT TritonTM) and specular microscopy (Perseus specular microscope). Being pseudophakic, underwent two trabeculectomy filtrating surgeries and, 5 years after the last one, she presented corneal decompensation. A standardized DMEK was performed, that resulted in a reduction of central corneal thickness and in an improvement of visual acuity. 2.5 years after the first DMEK, endothelial cell counts dropped and edema appeared again, with no signs of inflammation.

Results:

A second DMEK was performed, again, improving thickness, endothelial cell counts and visual acuity, with a follow up of 1 year.

Conclusions:

The patient presented a late onset failure, after 2 years of the corneal transplant, which seems to be the rule, according to literature, when treating ICE syndrome. DMEK is feasible and may be repeated on various occasions through the years because of this 2 year limit of graft survival.

Financial Disclosure:

None